News

July 26, 2021

Vator Securities advises Umecrine Cognition on 35 MSEK Private Placement

Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 35,1 million. Umecrine Cognition is developing golexanolone, a drug candidate with a completely new type of mechanism of action targeting the GABAA receptor in the brain.

» Read more

July 12, 2021

Vator Securities advises Plastics Unbound on 30 MSEK Private Placement

Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 30,3 million. Plastics Unbound has successfully completed technical and commercial validation through Tier-1 customer trials and production applications and is now transitioning into larger volume orders.

» Read more

July 9, 2021

Vator Swiss Nordic Bio 2022

VATOR SWISS NORDIC BIO 2022 – The Leading Annual European Healthcare Investor Summit in Zürich. Vator Securities and Business Sweden & partners have the pleasure to invite you to the annual European healthcare investor conference VATOR SWISS NORDIC BIO, connecting fast growing Nordic publicly listed healthcare companies, the most exciting start-ups, and the European investor community

» Read more

June 17, 2021

Vator Securities advises Xintela on 28 MSEK Directed Share Issues

Vator Securities acts as Sole Bookrunner in connection with the transactions raising SEK approximately SEK 28 million. Xintela is developing novel stem cell therapies and antibody based targeted cancer therapies using on the integrin marker technology platform XINMARK®. The patented stem cell product XSTEM®, produced in Xintela’s own GMP-facility, is entering a clinical phase I/IIa study in 2021. 

» Read more

June 11, 2021

Vator Securities advises JonDeTech on 32 MSEK Directed Share Issues

Vator Securities acts as Sole Bookrunner in connection with the transaction raising SEK approximately SEK 32,4 million. JonDeTech is a Swedish company that develops and markets patented IR sensor technology based on nanotechnology. The company's IR sensors are down to a tenth as thick as conventional sensors, produced in plastic and can be manufactured in high volumes at a low cost, which opens for a variety of applications in, among other things, consumer electronics and mobile phones. 

» Read more

June 10, 2021

Vator Securities advises ZignSec on 141 MSEK Directed Share Issues

Vator Securities acts as Global Coordinator and Sole Bookrunner in connection with the transactions raising SEK approximately SEK 141 million. The share issues are directed to a number of Swedish and international investors, including Lloyd Fonds, Altitude Capital, Consensus Asset Management and Knutsson Holdings.

» Read more

June 2, 2021

Boris Kotur joins Vator Securities as an Associate managing ECM transactions

Today, Boris Kotur joins Vator Securities as an Associate managing ECM transactions within our Corporate Finance team. Having spent the past four years with Vinge, one of the leading Swedish law firms, we are very excited to have Boris joining us. Hereby adding further talent to our platform serving our clients.

» Read more

June 1, 2021

Vator Tech Days – Focus: Technologies of Tomorrow

Vator Securities welcomes you to VatorTech Days - Technologies of Tomorrow, a digital event where you will have the opportunity to meet some of the most exciting companies working with the technology of the future in renewable energy and sustainable innovations. The event takes place on June 9th at 09:00 to 15:00. Among the participating companies are PowerCell Sweden, Soltech Energy Sweden, Re:Newcell, Nexam Chemical, Ljusgårda, Minesto, JonDeTech Sensors, Swedish Stirling AB, OXE Marine och Sivers Semiconductors.

» Read more

May 31, 2021

Vator Securities advises SciBase on 71 MSEK Directed Share Issues

Vator Securities acts as Sole Bookrunner in connection with the transactions raising SEK approximately SEK 71 million. The share issues are directed to a number of Swedish and international investors, including Van Herk Investments B.V. and ÖstVäst Capital Management, amongst others.

» Read more

May 28, 2021

Four new partners at Vator Securities

Vator Securities was established ten years ago and continues to expand. Hereby the promotion of four employees to new partners is announced: Erik Sjöström, Erik Röjvall, Felicia Rittemar, and Anders Arviken.  Through our new partners, Vator Securities further broadens and strengthens our knowledgebase. Acceding partners contribute with many years of professional experience and broad knowledge about, among other things, share analysis, project management, investment activities, and share management.

» Read more

May 6, 2021

Vator Tech Days – Focus: Gaming

Vator Securities welcomes you to Vator Tech Days – Focus: Gaming, a digital event where you get the opportunity to meet the most exciting fast-growing companies within Gaming and Esport. The event takes place on May 26th at 09:00 to 16:45. Among the participating companies are  Modern Times Group, Enad Global 7, Media and Games Invest, Thunderful Group, 11 Bit Studios (PL), Epulze, Flexion, Adverty, Qiiwi, Safe Lane Gaming, and MAG Interactive.

» Read more

April 13, 2021

Vator Securities advises Respiratorius on 25 MSEK Directed Share Issue

Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 25 million. Respiratorius AB is developing drug candidates with the goal to launch drugs for common diseases cancer, chronic obstructive pulmonary disease (COPD) and severe asthma. In addition, the project portfolio is a project for improved diagnosis of certain cardiovascular diseases.

» Read more

April 8, 2021

Vator Securities advises Sprint Bioscience on 21 MSEK Directed Share Issue

Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 21 million. Sprint Bioscience develops small-molecule first-in-class drug projects with a focus on oncology. With a fragment-based drug development method, the company develops drug projects in a time- and resource-efficient way that is outlicensed to global pharmaceutical companies during the preclinical phase.

» Read more

April 6, 2021

Vator Securities advises Epulze on 57 MSEK Private Placement

Vator Securities acts as Financial Adviser in connection with the transaction raising SEK 57 million. Epulze gives amateur players of computer games like Dota 2 and Counter-Strike: Global Offensive, the opportunity to participate in tournaments, leagues, and matches where real money is at stake. Among the new investors are well-known names such as Svea Ekonomi and Norwegian Carucel Finance, while Knutsson Holdings increases its ownership in the company.

» Read more

March 8, 2021

Vator Securities advises CombiGene on 75 MSEK Rights Issue

Vator Securities acts as Financial Adviser in connection with the transaction raising approximately SEK 75 million. Having established the production platform for CG01, CombiGene’s intention in 2021 is to focus on the final parts of the preclinical program for CG01 with two major preclinical studies, a biodistribution study and a safety study, which will be conducted together with CombiGene’s CRO partners Northern Biomedical Research and Neurochase.

» Read more

February 15, 2021

Vator Securities Events

Vator Securities Tech Days are investor events with some of the most interesting and fast-growing tech companies in the Nordics. Vator Securities presents a focused insight into the spectrum of tech companies including expert sessions related to the tech industry.

» Read more